Login / Signup

Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides.

Jaynee A HandelsmanSamya Z NasrCrystal PittsWilliam M King
Published in: Pediatric pulmonology (2017)
These results suggest that monitoring hearing alone is insufficient to detect ototoxicity in CF patients being treated with systemic AGS.
Keyphrases
  • cystic fibrosis
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • risk factors